Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea
· Delayed Price · Currency is KRW 18,390
-330 (-1.76%)
At close: Jun 27, 2025, 3:30 PM KST
Keeps Biopharma Revenue
Keeps Biopharma had revenue of 40.65B KRW in the quarter ending March 31, 2025, with 28.19% growth. This brings the company's revenue in the last twelve months to 136.52B, up 20.46% year-over-year. In the year 2024, Keeps Biopharma had annual revenue of 127.58B with 38.48% growth.
Revenue (ttm)
136.52B
Revenue Growth
+20.46%
P/S Ratio
2.88
Revenue / Employee
4.88B
Employees
28
Market Cap
392.97B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| NAVER | 11.00T |
| Doosan Enerbility | 15.88T |
| Hanwha Aerospace | 15.28T |